TAKEDA PHARMACEUTI (TKPYY)

20.32
0.21 1.04
NYSE
Prev Close 20.11
Open 20.15
Day Low/High 20.12 / 20.35
52 Wk Low/High 15.50 / 28.93
Volume 2.25M
Exchange NYSE
Shares Outstanding 794.70B
Market Cap 26.61B
Div & Yield N.A. (N.A)

Latest News

PepsiCo, Brett Kavanaugh, Fox and IHOP (or IHOb?) - 5 Things You Must Know

PepsiCo, Brett Kavanaugh, Fox and IHOP (or IHOb?) - 5 Things You Must Know

U.S. stock futures rise modestly on Tuesday as investors switch their focus to earnings season; Donald Trump announces that Brett Kavanaugh will be his second nominee for the Supreme Court; Fox is preparing a new bid for Sky PLC that would top Comcast's offer, a report says.

Investors Shift Focus to Earnings and 4 Other Stories to Watch Tuesday

Investors Shift Focus to Earnings and 4 Other Stories to Watch Tuesday

These are the stories to watch as investors shift focus to earnings season.

Dow Trims Earlier Losses, Finishes Slightly Higher After Volatile Session

Dow Trims Earlier Losses, Finishes Slightly Higher After Volatile Session

Stocks finished mixed on Tuesday after President Trump announced that the U.S. would withdraw from the Iran nuclear deal.

Global Stocks Mixed, Dollar Surging as Markets Await Trump Decision on Iran

Global Stocks Mixed, Dollar Surging as Markets Await Trump Decision on Iran

Oil pulled back from three-and-a-half year highs in overnight trading as markets await President Donald Trump's decision on renewed Iran sanctions that could pull a further 500,000 barrels of oil from the market each day.

Musk Buys 33,000 More Tesla Shares and 4 Other Stories You Must Know Tuesday

Musk Buys 33,000 More Tesla Shares and 4 Other Stories You Must Know Tuesday

Here's what you need to know as futures point lower heading into the open.

Takeda Pharmaceutical Agrees $62.4 Billion Takeover of Shire

Takeda Pharmaceutical Agrees $62.4 Billion Takeover of Shire

Japan's biggest drugmaker, Takeda Pharmaceutical Co., looks to have wrapped up its bid to buy Dublin-based Shire plc for $62.4 billion in cash and shares.

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Stocks rise after stronger-than-expected earnings from Boeing and Twitter.

Daily Chatter: Here's Where the Markets Stand After Tuesday's Beating

Daily Chatter: Here's Where the Markets Stand After Tuesday's Beating

Global stocks are on the defensive Wednesday, pulling U.S. futures and European shares lower, as investor re-set expectations for corporate profits in the face of rising investment and input costs.

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

U.S. stocks attempted to reverse the global tide Wednesday, with futures improving after better-than-expected earnings from Boeing and Twitter and a spate of multi-billion merger deals at home and abroad.

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

U.S. stock futures point to further losses for Wall Street and global stocks slump on Wednesday; Facebook, Boeing and AMD report earnings; Takeda sweetens offer for Shire.

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

As Wall Street prepares for another rough day, these are the business stories you must know.

The Global Stock Market Rout Spreads Across the World

The Global Stock Market Rout Spreads Across the World

Global stocks are on the defensive Wednesday, pulling U.S. futures and European shares lower, as investor re-set expectations for corporate profits in the face of rising investment and input costs.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Dow fell triple digits after starting the day off in the green.

Here's My Take on Biotech Stocks

Here's My Take on Biotech Stocks

I think M&A activity will pick up markedly going forward across the industry.

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Stocks rise Monday as concerns over prolonged military action in Syria fade and the focus for investors shifts to a heavy upcoming slate of U.S. corporate earnings.

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

U.S. equity futures gave back earlier gains Monday even as investor concern over prolonged military action in Syria faded following weekend missile strikes in reaction to an alleged chemicals weapons attack last week in the city of Douma.

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire will sell its oncology business to France's Servier for around $2.4 billion as it contemplates a possible $50 billion takeover from Japan's Takeda Pharmaceutical Co.

U.S. Futures Up, Global Markets Mixed on Geopolitical Tension

U.S. Futures Up, Global Markets Mixed on Geopolitical Tension

Oil remained near a three-year high despite falling back slightly on Thursday.

Dow, S&P Suffer Worst Day of Trading in 2 Weeks

Dow, S&P Suffer Worst Day of Trading in 2 Weeks

China on Friday said it would counter Trump's proposed new tariffs 'to the end, and at any cost'

Global Stocks, Wall Street Futures Up as Trade Worries Ease

Global Stocks, Wall Street Futures Up as Trade Worries Ease

Wall Street is also expected to start the day in positive territory on Thursday after tumultuous trading on Wednesday.

The Dow Falls Into Wednesday's Close

The Dow Falls Into Wednesday's Close

Strength in the morning yields to weakness in the afternoon session as stocks are sold off Wednesday.

Takeda Pharmaceutical Confirms Takeover Interest in U.K.-Listed Shire Plc

Takeda Pharmaceutical Confirms Takeover Interest in U.K.-Listed Shire Plc

Shire Pharmaceuticals shares hit a year-to-date high Wednesday after Japan's biggest drugmaker, Takeda, confirmed it may make a takeover approach for the U.K.-listed group.

The Next Target in Biotech Land

The Next Target in Biotech Land

The Actelion buyout opens the way for other deals.

The Next Target in Biotech Land

The Next Target in Biotech Land

The Actelion buyout opens the way for other deals.

4 Biotech Names That Could Be M&A Targets

4 Biotech Names That Could Be M&A Targets

Animal health and oncology deal activity is heating up in 2017.

Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal

Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal

Shares of Ariad Pharmaceuticals soared Monday after Japan's Takeda Pharmaceutical offered to buy the leukemia drug maker.

A Very Happy New Year for Investors in Japan

A Very Happy New Year for Investors in Japan

The Nikkei 225 closed with a gain for 2016, making a run of five consecutive higher year-end closes -- the first since the 1990 bubble.